New master trial aims to match immunotherapy to each Patient's tumor before surgery

NCT ID NCT07262489

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests giving immunotherapy before surgery for cancers that haven't spread. It uses a rapid blood and tumor test to match each patient to the treatment most likely to work for them. The goal is to shrink tumors, boost the immune system, and lower the chance of cancer coming back. About 200 people will take part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALIZED CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Gustave Roussy

    RECRUITING

    Villejuif, 94800, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.